Skip to Content


Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.




The invention provides a method for the controlled delivery of a drug as a function of bioavailable drug concentration, a sensor device for detecting bioavailable drug concentration, and a delivery device that controls delivery of the drug based on the real-time detection of bioavailable drug concentration. Announcement is made of the availability for licensing of the invention set forth in International Patent Application No. PCT/US2009/060852 entitled, “Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample,” filed on October 15, 2009 (which claims the benefit of U.S. Provisional Patent Application Serial No. 651/105,604 filed October 15, 2008). The United States Government, as represented by the Secretary of the Army, has rights to this invention. U.S. and selected foreign rights are available.


Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.


For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.


The invention relates to the method of electrochemical detection of bioavailable drug concentration intended to be used to modify the delivery rate of the drug to a patient during real-time.

Brenda S. Bowen,

Army Federal Register Liaison Officer.

[FR Doc. 2012-18 Filed 1-5-12; 8:45 am]